Meguro, Japan

Kyozo Naito


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 27(Granted Patents)


Location History:

  • Meguro, JP (1994)
  • Tokyo, JP (1995)

Company Filing History:


Years Active: 1994-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kyozo Naito: Innovator in Pharmaceutical Chemistry

Introduction

Kyozo Naito is a notable inventor based in Meguro, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to his name, Naito's work has the potential to impact various medical treatments.

Latest Patents

Naito's latest patents include the invention of a physiologically active substance known as BE-16627. This invention relates to new stromelysin (human)-inhibitors, represented by a specific general formula. The compound is characterized by its potential use in pharmaceutical applications, including a process for its production and the identification of a microorganism that produces BE-16627. Another significant patent involves guanidinobenzene derivatives, which are represented by a specific formula. This invention includes a process for production and an antiviral pharmaceutical composition that incorporates the compound.

Career Highlights

Kyozo Naito has been associated with Banyu Pharmaceutical Co. Ltd., where he has contributed to various research initiatives. His work focuses on developing innovative solutions to address medical challenges through chemical compounds.

Collaborations

Naito has collaborated with notable colleagues, including Akira Okuyama and Hidetoshi Ogino. These collaborations have fostered a productive environment for research and innovation in pharmaceutical chemistry.

Conclusion

Kyozo Naito's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…